Immunomodulation: Clinical Trials

6 trials of Immunomodulation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 2 unknown, 1 completed, 1 enrolling by invitation. 3 Phase 2, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 23Completed 1, Enrolling by invitation 1, Recruiting 1
Phase 11Enrolling by invitation 1
Phase 41Unknown 1

Follow Immunomodulation: new trials by email Literature Review of Immunomodulation trials Research Report on Immunomodulation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autism Spectrum Disorder (ASD) Neurodevelopmental Disorder With Issues Social Behavior, Communication Issues, GI Dysfunction. Study is Multimodal Interventions Targeting These Pathways With cSVF, Stored MSCs, FMT and Diet Modification. Role of Autoimmunity, Gut-brain Issues, & Issues Examined.
Autologous MSC isolation, concentration, and cryopreservation of adult mesenchymal stem cells, Fecal Biomicrome Transplantation (FMT), Ketogenic RESET Diet Protocol - Autism Spectrum Disorder, Autism
Phase 1 / Phase 2Enrolling by invitationBlack Tie Medical, Inc.502026-04-302026-04-27
Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma
Radiochemoimmunotherapy, Immunomodulation - Gastric Cancer
Phase 2RecruitingThe First Affiliated Hospital with Nanjing Medical University482025-12-162026-03-19
SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION
Immunomodulation - Immunodeficiency, Autoimmune Diseases
RecruitingKarolinska Institutet5002024-01-012024-02-08
Pre-emptive Immunomodulation After Allogeneic Stem Cell Transplantation in AML
immunomodulation - AML
UnknownUniversity Hospital, Caen602016-06-012019-04-22
To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis B
PEG-IFN & Nucleos(t)tide analogues, Nucleos(t)tide analogues - Hepatitis B
Phase 4UnknownKing Abdullah International Medical Research Center2142015-03-012018-03-09
Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients
ART Intensification, Immunomodulation - HIV-1 Infection
Phase 2CompletedObjectif Recherche Vaccins SIDA292010-09-012013-06-13

Conditions studied

Autism Spectrum Disorder (1)  ·  Autistic Disorder (1)  ·  Autoimmune Diseases (1)  ·  Communication (1)  ·  Hepatitis B (1)  ·  Hypersensitivity (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Intestinal Diseases (1)  ·  Learning Disabilities (1)  ·  Stomach Neoplasms (1)

Sponsors

Black Tie Medical, Inc. (1)  ·  Karolinska Institutet (1)  ·  King Abdullah International Medical Research Center (1)  ·  Objectif Recherche Vaccins SIDA (1)  ·  The First Affiliated Hospital with Nanjing Medical University (1)  ·  University Hospital, Caen (1)

Countries

France (2)  ·  China (1)  ·  Italy (1)  ·  Saudi Arabia (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Abduljaleel Alalwan, MD (1)

Results publications

PMID 26684819

NIH funding

2023 (1)